Srinagar, 04 April 2026: Medanta– The Medicity, ranked the best hospital in India by Newsweek in 2026, is an internationally known destination for Deep Brain Stimulation (DBS) therapy, also known as ‘Brain-Pacemaker surgery’. This cutting-edge neurostimulation procedure, spearheaded by Dr. Anirban Deep Banerjee, Director-Neurosurgery at the Institute of Neurosciences, Medanta, employs advanced imaging techniques for precise brain targeting and utilizes state-of-the-art innovations such as real-time brain-sensing biomarker feedback for symptom-responsive stimulation.

Explaining the procedure, Dr. Anirban Deep Banerjee, Director-Neurosurgery at the Institute of Neurosciences, Medanta, said, “DBS or Brain Pacemaker Surgery is a transformative therapy wherein electrodes are implanted in specific affected areas of the brain to regulate abnormal signals, restoring motor function, and greatly enhancing quality of life. It is known to bring relief to advanced-stage symptoms of Parkinson’s disease, dystonia, epilepsy (adult onset), essential tremor, and obsessive-compulsive disorder (OCD).”

This technology uses tiny implanted electrodes to read brain signals and understand how the brain is functioning. By correlating these signals with a patient’s symptoms, doctors gain clear, measurable insights that help fine-tune DBS therapy more precisely, resulting in better and more consistent symptom control over time.

Highlighting the growing burden of neurological disorders in India, Dr. Anirban Deep Banerjee, Director-Neurosurgery at the Institute of Neurosciences, Medanta, said, “Neurological conditions are among the leading causes of disability worldwide and account for nearly 10% of our country’s total disease burden. While advanced treatments like DBS can significantly improve patient outcomes, access to such therapies remains a key challenge.”

Despite the availability of effective treatments, awareness and access remain limited. At Medanta, DBS therapy has already transformed the lives of hundreds of patients, including Mr. Yassir Shah (name changed) from Srinagar, Jammu resident Mrs. Harmeet Kour and Mr. Gandharv Chand from Udhampur.

Mr. Shah, in his 60s, who was diagnosed with advanced Parkinson’s disease, was suffering from severe camptocormia or bent spine syndrome -- a condition that causes a marked bending of the spine. Under Dr. Banerjee’s care, DBS electrodes were placed in specific areas of his brain that control movement and posture, which sent controlled electrical signals to regulate the circuits responsible for the bent posture. Sharing his experience, the patient said, “My spine had become so bent that I was close to losing mobility. After undergoing DBS treatment, I began to see improvement within a few weeks.”

Parkinson’s had also significantly impacted Mrs. Kour’s daily life, making even simple tasks difficult, such as holding a cup. By the time she consulted Dr. Banerjee, her condition had progressed to an advanced stage. The 60-year-old shared, “After undergoing brain pacemaker surgery, my symptoms improved dramatically. With regular device tuning, my condition is now well managed, and the care I received has truly changed my life.”

Mr. Chand, meanwhile, witnessed a significant improvement in his symptoms following DBS surgery, with his tremors resolving. This allowed him to regain independence and confidence in everyday activities that had earlier been difficult. The procedure proved transformative, greatly enhancing his quality of life and empowering him to manage his daily routine with renewed assurance.

With over 300 successful DBS procedures performed over the past 15 years, Dr. Banerjee is widely regarded as a leading expert in this field. Medanta’s DBS program integrates advanced technologies such as AI-guided brain targeting and remote programming, enabling more precise treatment and continuous care. These innovations are particularly beneficial for patients from smaller cities like Srinagar and Jammu, as they reduce the need for frequent travel to Metros for follow-up care.

Dr. Banerjee said, “In addition, we have also launched AI-guided Adaptive DBS, which monitors brain activity and automatically adjusts treatment in real time, reducing the need for frequent doctor-led reprogramming sessions that were earlier required.”